| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1016414A2 Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans |
| 07/05/2000 | EP1016413A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/05/2000 | EP1015616A2 Intrabody-mediated control of immune reactions |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015496A2 Immuntoxins and methods of inducing immune tolerance |
| 07/05/2000 | EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 07/05/2000 | EP1015450A1 Novel pyridazine compounds |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015422A1 Hiv matrix protein tyrosine position 29 pocket binders |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1015035A1 Vaccination by topical application of genetic vectors |
| 07/05/2000 | EP1015034A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 07/05/2000 | EP1015028A2 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 07/05/2000 | EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 07/05/2000 | EP1015025A1 T-cell vaccination for the treatment of multiple sclerosis |
| 07/05/2000 | EP1015024A1 Antigen presenting mesenchymal stem cells |
| 07/05/2000 | EP1015012A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1015003A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014972A1 Method of treatment and pharmaceutical composion |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP1014787A1 Adjuvant for transcutaneous immunization |
| 07/05/2000 | EP0876392B1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | EP0675889B1 Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | EP0563168B1 Xanthine derivatives |
| 07/05/2000 | CN1259117A 2-aminopropane-1,3-diol compounds medicinal use thereof and intermediates in synthesizing the same |
| 07/05/2000 | CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor |
| 07/05/2000 | CN1258512A Lycium chinense glycopeptide and its production process |
| 07/05/2000 | CN1054045C Health medicated wine |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6084067 CTLA4/CD28 ligands and uses therefor |
| 07/04/2000 | US6083992 Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial infections |
| 07/04/2000 | US6083974 Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 07/04/2000 | US6083959 Quinoline derivatives, processes for their preparation and their use as medicaments |
| 07/04/2000 | US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders |
| 07/04/2000 | US6083925 Nucleic acid respiratory syncytial virus vaccines |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083521 Drugs and polyethylene carbonates |
| 07/04/2000 | US6083510 High molecular weight extracts of Convolvulus arvensis field (field bindweed) |
| 07/04/2000 | US6083505 Immunogen/vaccine adjuvant composition containing an immunogen in an amount effective to stimulate an immune response and as a vaccine adjuvant a 1h-imidazo(4,5-c)quinolin-4-amine in an amount effective to increase the immune response to the |
| 07/04/2000 | US6083503 Administering an antigen specifically recognized by t cells to cause the t cells that specifically recognize the antigen to express interleukin-2 or il-2 receptors, such that the t cell immune response to the antigen is inhibited |
| 07/04/2000 | CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037504A2 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | WO2000037493A2 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037481A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb¿1? |
| 06/29/2000 | WO2000037470A1 Antihistaminic spiro compounds |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO2000037106A1 Oral vaccine against diarrhea |
| 06/29/2000 | WO2000037102A2 Improvement of tolerance to a xenograft |
| 06/29/2000 | WO2000037101A1 Method to produce inactivated w/o emulsion adjuvated vaccines |
| 06/29/2000 | WO2000037094A2 Therapeutic applications of flint polypeptides |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 06/29/2000 | WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | WO2000037075A1 Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant |
| 06/29/2000 | WO2000037067A2 Sensitizing agents for the treatment of skin lesions |
| 06/29/2000 | WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | WO2000037027A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
| 06/29/2000 | WO2000014262A3 Methylation of plasmid vectors |
| 06/29/2000 | WO2000012175A3 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases |
| 06/29/2000 | WO2000012129A3 Salmonella typhi vaccine compositions |
| 06/29/2000 | WO2000010547A3 New use of taxoid derivatives |
| 06/29/2000 | WO2000001409A3 Porcine circovirus and parvovirus vaccine |
| 06/29/2000 | WO2000000594A3 Human transferases |
| 06/29/2000 | WO1999003881A3 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 06/29/2000 | DE19954305A1 Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie Peptides of AT¶1¶ receptor and their use, in particular for pre-eclampsia Diagnostider |
| 06/29/2000 | DE19860371A1 Kosmetische oder medizinische Zubereitung für die topische Anwendung Cosmetic or medical composition for topical application |
| 06/29/2000 | CA2358508A1 Therapeutic applications of flint polypeptides |
| 06/29/2000 | CA2357413A1 Sensitizing agents for the treatment of skin lesions |
| 06/29/2000 | CA2356764A1 Type iii secretion system antigens from bordetella pertussis |
| 06/29/2000 | CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
| 06/29/2000 | CA2356215A1 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | CA2356159A1 Novel spla2 inhibitors |
| 06/29/2000 | CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |